Cubist Systematic Strategies’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,474
| Closed | -$123K | – | 3448 |
|
|
2024
Q1 | $123K | Buy |
3,474
+2,528
| +267% | +$101K | ﹤0.01% | 3218 |
|
|
2023
Q4 | $41.2K | Sell |
946
-17,211
| -95% | -$677K | ﹤0.01% | 3291 |
|
|
2023
Q3 | $693K | Sell |
18,157
-196
| -1% | -$8.25K | 0.01% | 2119 |
|
|
2023
Q2 | $755K | Sell |
18,353
-6,118
| -25% | -$294K | 0.01% | 2132 |
|
|
2023
Q1 | $1.4M | Sell |
24,471
-16,641
| -40% | -$938K | 0.01% | 1925 |
|
|
2022
Q4 | $2.31M | Sell |
41,112
-121,011
| -75% | -$6.16M | 0.01% | 1730 |
|
|
2022
Q3 | $6.87M | Sell |
162,123
-150,738
| -48% | -$7.72M | 0.04% | 778 |
|
|
2022
Q2 | $16.9M | Buy |
312,861
+247,813
| +381% | +$14.9M | 0.1% | 190 |
|
|
2022
Q1 | $4.18M | Buy |
65,048
+25,350
| +64% | +$1.67M | 0.04% | 863 |
|
|
2021
Q4 | $2.66M | Buy |
39,698
+34,651
| +687% | +$2.34M | 0.03% | 1126 |
|
|
2021
Q3 | $346K | Sell |
5,047
-11,648
| -70% | -$823K | ﹤0.01% | 2270 |
|
|
2021
Q2 | $1.14M | Buy |
16,695
+9,359
| +128% | +$662K | 0.01% | 1473 |
|
|
2021
Q1 | $507K | Buy |
7,336
+3,845
| +110% | +$260K | 0.01% | 1946 |
|
|
2020
Q4 | $227K | Buy |
+3,491
| New | +$188K | ﹤0.01% | 2171 |
|
|
2020
Q3 | – | Sell |
-13,617
| Closed | -$640K | – | 2547 |
|
|
2020
Q2 | $640K | Sell |
13,617
-20,617
| -60% | -$1.01M | 0.01% | 1455 |
|
|
2020
Q1 | $1.53M | Sell |
34,234
-11,009
| -24% | -$578K | 0.04% | 598 |
|
|
2019
Q4 | $2.64M | Buy |
45,243
+40,070
| +775% | +$2.39M | 0.05% | 603 |
|
|
2019
Q3 | $311K | Sell |
5,173
-13,518
| -72% | -$805K | 0.01% | 1537 |
|
|
2019
Q2 | $1.04M | Sell |
18,691
-8,271
| -31% | -$426K | 0.02% | 1016 |
|
|
2019
Q1 | $1.5M | Sell |
26,962
-9,581
| -26% | -$488K | 0.05% | 562 |
|
|
2018
Q4 | $1.65M | Buy |
+36,543
| New | +$2M | 0.08% | 359 |
|
|
2018
Q3 | – | Sell |
-21,487
| Closed | -$1.38M | – | 1973 |
|
|
2018
Q2 | $1.38M | Buy |
+21,487
| New | +$1.33M | 0.07% | 355 |
|
|
2018
Q1 | – | Sell |
-6,689
| Closed | -$320K | – | 1937 |
|
|
2017
Q4 | $320K | Buy |
+6,689
| New | +$327K | 0.02% | 1207 |
|
|
2016
Q4 | – | Sell |
-34,462
| Closed | -$1.42M | – | 1789 |
|
|
2016
Q3 | $1.42M | Buy |
34,462
+34,068
| +8,647% | +$1.43M | 0.09% | 294 |
|
|
2016
Q2 | $16K | Sell |
394
-6
| -2% | -$216 | ﹤0.01% | 1646 |
|
|
2016
Q1 | $13K | Buy |
400
+10
| +3% | +$311 | ﹤0.01% | 1549 |
|
|
2015
Q4 | $13K | Sell |
390
-35,280
| -99% | -$1.1M | ﹤0.01% | 1693 |
|
|
2015
Q3 | $1.06M | Buy |
+35,670
| New | +$1.12M | 0.05% | 548 |
|
Other funds holding IART
CB
Cubist Systematic Strategies's IART Position: Q2 2024 in Review
Cubist Systematic Strategies sold out of Integra LifeSciences (IART) in Q2 2024, closing a stake of 3,474 shares — an estimated $123K sold.
Cubist Systematic Strategies first reported a position in IART in Q3 2015 and held it in 28 quarters. The position peaked at $16.9M in Q2 2022. 238 funds tracked by Wall St. Rank hold IART as of Q2 2024.
- Cubist Systematic Strategies reported no remaining Integra LifeSciences position as of Q2 2024 after selling out during the quarter.
- Cubist Systematic Strategies sold 3,474 Integra LifeSciences shares in Q2 2024, an estimated $123K.
- Cubist Systematic Strategies first reported a position in Integra LifeSciences in Q3 2015 and held it in 28 quarters.
- Cubist Systematic Strategies's Integra LifeSciences position peaked at $16.9M in Q2 2022.
- 238 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2024.
Based on Cubist Systematic Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.